Karyopharm Therapeutics inc (KPTI) Q2 2021 Earnings Call Transcript

·44-min read
Karyopharm Therapeutics inc (KPTI) Q2 2021 Earnings Call Transcript

At this time, I would like to welcome everyone to the Karyopharm Therapeutics Second Quarter 2021 Financial Results Conference Call. Today, I'm joined by Mr. Richard Paulson, President and Chief Executive Officer; Ms. Sohanya Cheng, Senior Vice President, Sales and Commercial Operations; Dr. Jatin Shah, Chief Medical Officer; Mr. Mike Mason Chief Financial Officer; Dr. Sharon Shacham, Chief Scientific Officer; and Mr. Stephen Mitchener, Chief Business Officer.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting